Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Use Investigation of Riociguat for Pulmonary Arterial Hypertension (PAH)

NCT02428985 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02428985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02428985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Use Investigation of Riociguat for Pulmonary Arterial Hypertension (PAH)
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
June 29, 2015
Completion date
September 20, 2023
Enrollment
882 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, pulmonary